# Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration in Adult Living Donor Liver Transplant (LDLT) Recipients.

> **NCT07664020** · NA · NOT_YET_RECRUITING · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 130 (estimated)

## Conditions studied

- Chronic Liver Disease

## Interventions

- **DRUG:** Ursodeoxycholic acid
- **OTHER:** Standard Medical Treatment

## Key facts

- **NCT ID:** NCT07664020
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-18
- **Primary completion:** 2027-11-01
- **Final completion:** 2027-11-01
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2026-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07664020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07664020, "Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration in Adult Living Donor Liver Transplant (LDLT) Recipients.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07664020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*